HTG Molecular Diagnostics, Inc
HTGMDelisted Jul 10, 2023- Industry
- Laboratory Analytical Instruments
- SEC CIK
- 0001169987
HTG Molecular Diagnostics, Inc was delisted on Jul 10, 2023; its insiders filed their last Form 4 on Jun 9, 2023; 12 institutions reported holding it in 13F filings for Q1 2023, worth $67.3K in total; no superinvestor held it.
13F holders, Q1 2022
Institutional positions in HTG Molecular Diagnostics, Inc as of Mar 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 22
- −1 vs. Q4 2021
- Shares held
- 2.30M
- −381.9K (−14.3%) vs. Q4 2021
- Total value
- $3.19M
- −$11.3M (−78.0%) vs. Q4 2021
- New holders
- 5
- 6 more added
- Sold out
- 6
- 3 more reduced
Compare with Q4 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting HTGM on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 0 | $0 |
| Q4 2023 | 0 | $0 |
| Q3 2023 | 0 | $0 |
| Q2 2023 | 0 | $0 |
| Q1 2023 | 12 | $67.3K |
| Q4 2022 | 10 | $66.2K |
| Q3 2022 | 19 | $283.0K |
| Q2 2022 | 22 | $622.0K |
| Q1 2022 | 22 | $3.19M |
| Q4 2021 | 23 | $14.5M |
| Q3 2021 | 23 | $16.4M |
| Q2 2021 | 25 | $19.7M |
| Q1 2021 | 23 | $11.2M |
Institutions, Q1 2022
Shares, value and share of portfolio for each institution holding HTG Molecular Diagnostics, Inc; share changes are against Q4 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| JPMorgan Chase & Co | 337 | $0 | 0.00% | +310+1,148.1% | Added |
| Wells Fargo & Company | 41 | $0 | 0.00% | +1+2.5% | Added |
| TCI Wealth Advisors, Inc. | 26 | $0 | 0.00% | 00.0% | Unchanged |
| Surevest, LLC | 1 | $0 | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 13 | $0 | 0.00% | 00.0% | Unchanged |
| 1832 Asset Management L.P. | 66 | $0 | 0.00% | +66 | New |
| Tower Research Capital LLC (TRC) | 1,265 | $2.00K | 0.00% | +1,265 | New |
| Citigroup Inc | 3,000 | $4.00K | 0.00% | +3,000 | New |
| Allworth Financial LP | 3,327 | $5.00K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 4,000 | $6.00K | 0.00% | +1,762+78.7% | Added |
| HighMark Wealth Management LLC | 6,966 | $10.0K | 0.01% | 00.0% | Unchanged |
| State Street Corp | 14,455 | $20.0K | 0.00% | +412+2.9% | Added |
| Morgan Stanley | 14,763 | $21.0K | 0.00% | +11,933+421.7% | Added |
| BlackRock Inc. | 15,811 | $22.0K | 0.00% | 00.0% | Unchanged |
| Millennium Management LLC | 27,492 | $38.0K | 0.00% | +27,492 | New |
| Geode Capital Management, LLC | 46,039 | $63.0K | 0.00% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 55,516 | $77.0K | 0.00% | +900+1.6% | Added |
| Vanguard Group Inc | 245,766 | $341.0K | 0.00% | 00.0% | Unchanged |
| Nantahala Capital Management, LLC | 285,963 | $397.0K | 0.03% | −49,052−14.6% | Reduced |
| Cowen Prime Advisors LLC | 332,197 | $462.0K | 0.19% | −260,936−44.0% | Reduced |
| Samjo Capital LLC | 404,963 | $563.0K | 0.48% | −185,037−31.4% | Reduced |
| Armistice Capital, LLC | 834,054 | $1.16M | 0.03% | +834,054 | New |
| AIGH Capital Management LLC | 0 | $0 | 0.00% | −612,000−100.0% | Sold out |
| Worth Venture Partners, LLC | 0 | $0 | 0.00% | −143,135−100.0% | Sold out |
| Kellett Schaffner Wealth Advisors LLC | 0 | $0 | 0.00% | −11,333−100.0% | Sold out |
| Migdal Insurance & Financial Holdings Ltd. | 0 | $0 | 0.00% | −1,316−100.0% | Sold out |
| Fortitude Advisory Group L.L.C. | 0 | $0 | 0.00% | −288−100.0% | Sold out |
| Cornerstone Advisory, LLC | 0 | $0 | 0.00% | −1−100.0% | Sold out |